EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-Interventional, Retrospective, Multicenter Study on the Renal Safety of Liposomal Amphotericin B in Critically Ill Patients with Invasive Pulmonary Aspergillosis

Borja Suberviola iD, Jose Peral Gutierrez de Ceballos iD, Maria Jose Asensio Martin, Cruz Soriano Cuesta, Rafael Zaragoza iD, Lorena Forcelledo, Iratxe Seijas, Miguel Santibanez iD

Journal of Fungi · 23.06.2026 · 12 (7) · 458

DOI: 10.3390/jof12070458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Fungi, online erschienen am 23.06.2026. Verfasst von Borja Suberviola und 7 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Department, University Hospital Marques de Valdecilla, Valdecilla Research Institute (IDIVAL), 39008 Santander, Spain. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to determine the incidence of kidney injury associated with liposomal amphotericin B (L-AmB) treatment, based on RIFLE criteria, in patients admitted to the intensive care unit (ICU) with invasive pulmonary aspergillosis (IPA). Materials and Methods: A retrospective, multicenter observational study including patients treated with L-AmB for IPA while admitted to the ICU between 1 January 2015, and 31 December 2022.

Results

A total of 65 patients were included. The prevalence of renal failure was 35.39%. Renal failure was mostly mild and reversible. The need for major surgery (OR 6.71; p = 0.121) and concomitant use of other nephrotoxic treatments (OR 2.5; p = 0.194) emerged as potential risk factors for the development of renal failure; however, neither association reached statistical significance. Overall mortality was 66.2%, significantly higher in the group with renal failure (82.6% vs. 57.1%; p = 0.03). Factors associated with mortality included concomitant use of other nephrotoxic agents (OR 4.51; p = 0.024) and development of renal failure (OR 3.66; p = 0.068). Duration of L-AmB treatment was not associated with mortality. Regarding creatinine recovery, all patients who developed renal failure but survived showed creatinine levels below 1.5 mg/dL after completion of treatment.

Conclusions

Renal impairment was common in this high-risk population of critically ill patients, with renal function impairment in one-third of exposed patients, although most cases were mild. In this population, concomitant administration of other nephrotoxic drugs was associated with both renal failure and mortality. Treatment duration with L-AmB was not linked to mortality, and creatinine levels normalized after therapy completion.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injurycritically ill patientsinvasive pulmonary aspergillosisliposomal amphotericin Bnephrotoxicity

Autor:innen und Institutionen

  • Intensive Care Department, University Hospital Marques de Valdecilla, Valdecilla Research Institute (IDIVAL), 39008 Santander, Spain.
  • Intensive Care Department, University Hospital Gregorio Marañon, 28007 Madrid, Spain.
  • Intensive Care Department, University Hospital La Paz, IdiPAZ, 28046 Madrid, Spain.
  • Intensive Care Department, University Hospital Ramon y Cajal, 28034 Madrid, Spain.
  • Intensive Care Department, University Hospital Dr. Peset, 46017 Valencia, Spain.
  • Intensive Care Department, University Hospital Central de Asturias, 33011 Oviedo, Spain.

ORCID-Profile: Borja Suberviola, Jose Peral Gutierrez de Ceballos, Rafael Zaragoza, Miguel Santibanez

Förderung

  • Gilead Sciences

Zitieren

APA

Suberviola, B., Ceballos, J. P. G., Martin, M. J. A., Soriano Cuesta, C., Zaragoza, R., Forcelledo, L., Seijas, I., & Santibanez, M. (2026). Non-Interventional, Retrospective, Multicenter Study on the Renal Safety of Liposomal Amphotericin B in Critically Ill Patients with Invasive Pulmonary Aspergillosis. Journal of Fungi, 12(7), 458. https://doi.org/10.3390/jof12070458

Vancouver

Suberviola B, Ceballos JPG, Martin MJA, Soriano Cuesta C, Zaragoza R, Forcelledo L, et al. Non-Interventional, Retrospective, Multicenter Study on the Renal Safety of Liposomal Amphotericin B in Critically Ill Patients with Invasive Pulmonary Aspergillosis. Journal of Fungi. 2026;12(7):458. doi:10.3390/jof12070458

BibTeX
@article{Suberviola2026,
  author = {Suberviola, Borja and Ceballos, Jose Peral Gutierrez de and Martin, Maria Jose Asensio and Soriano Cuesta, Cruz and Zaragoza, Rafael and Forcelledo, Lorena and Seijas, Iratxe and Santibanez, Miguel},
  title = {Non-Interventional, Retrospective, Multicenter Study on the Renal Safety of Liposomal Amphotericin B in Critically Ill Patients with Invasive Pulmonary Aspergillosis},
  journal = {Journal of Fungi},
  year = {2026},
  volume = {12},
  number = {7},
  pages = {458},
  doi = {10.3390/jof12070458}
}
Kostenlos starten →